PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Oxylan
Presentation Product Chemical substance Chapter Items dispensed
Oxylan 10mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFABAF
Oxylan Oxycodone hydrochloride Central Nervous System 637
Oxylan 5mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFAAAK
Oxylan Oxycodone hydrochloride Central Nervous System 541
Oxylan 20mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFACAG
Oxylan Oxycodone hydrochloride Central Nervous System 439
Oxylan 40mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFADAH
Oxylan Oxycodone hydrochloride Central Nervous System 122
Oxylan 30mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFALAR
Oxylan Oxycodone hydrochloride Central Nervous System 78
Oxylan 15mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFAKAS
Oxylan Oxycodone hydrochloride Central Nervous System 54
Oxylan 80mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFAEAI
Oxylan Oxycodone hydrochloride Central Nervous System 36
Oxylan 60mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFAMAQ
Oxylan Oxycodone hydrochloride Central Nervous System 27
Oxylan 10mg modified-release tablets (Actavis)
0407020ADBFAGAF
Oxylan Oxycodone hydrochloride Central Nervous System No data available
Oxylan 20mg modified-release tablets (Actavis)
0407020ADBFAHAG
Oxylan Oxycodone hydrochloride Central Nervous System No data available
Oxylan 40mg modified-release tablets (Actavis)
0407020ADBFAIAH
Oxylan Oxycodone hydrochloride Central Nervous System No data available
Oxylan 5mg modified-release tablets (Actavis)
0407020ADBFAFAK
Oxylan Oxycodone hydrochloride Central Nervous System No data available
Oxylan 80mg modified-release tablets (Actavis)
0407020ADBFAJAI
Oxylan Oxycodone hydrochloride Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.